New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, shows that patients with refractory juvenile systemic sclerosis improved significantly on nearly all measures for two years following autologous stem cell transplant.
from News Medical Medical Research News Feed https://ift.tt/3Lc9xiB
0 Comments